Your browser doesn't support javascript.
loading
Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
Boekhoud, Ilse M; Sidorov, Igor; Nooij, Sam; Harmanus, Céline; Bos-Sanders, Ingrid M J G; Viprey, Virginie; Spittal, William; Clark, Emma; Davies, Kerrie; Freeman, Jane; Kuijper, Ed J; Smits, Wiep Klaas.
Afiliação
  • Boekhoud IM; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Sidorov I; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Nooij S; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Harmanus C; Center for Microbiome Analyses and Therapeutics, Leiden University Medical Center, Leiden, The Netherlands.
  • Bos-Sanders IMJG; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Viprey V; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Spittal W; Healthcare Associated Infection Research Group, School of Medicine, University of Leeds, Leeds, UK.
  • Clark E; Healthcare Associated Infection Research Group, School of Medicine, University of Leeds, Leeds, UK.
  • Davies K; Healthcare Associated Infection Research Group, School of Medicine, University of Leeds, Leeds, UK.
  • Freeman J; Healthcare Associated Infection Research Group, School of Medicine, University of Leeds, Leeds, UK.
  • Kuijper EJ; European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Study Group for Clostridioides difficile (ESGCD), Basel, Switzerland.
  • Smits WK; Healthcare Associated Infection Research Group, School of Medicine, University of Leeds, Leeds, UK.
J Antimicrob Chemother ; 76(7): 1731-1740, 2021 06 18.
Article em En | MEDLINE | ID: mdl-33876817
ABSTRACT

BACKGROUND:

Until recently, metronidazole was the first-line treatment for Clostridioides difficile infection and it is still commonly used. Though resistance has been reported due to the plasmid pCD-METRO, this does not explain all cases.

OBJECTIVES:

To identify factors that contribute to plasmid-independent metronidazole resistance of C. difficile.

METHODS:

Here, we investigate resistance to metronidazole in a collection of clinical isolates of C. difficile using a combination of antimicrobial susceptibility testing on different solid agar media and WGS of selected isolates.

RESULTS:

We find that nearly all isolates demonstrate a haem-dependent increase in the MIC of metronidazole, which in some cases leads to isolates qualifying as resistant (MIC >2 mg/L). Moreover, we find an SNP in the haem-responsive gene hsmA, which defines a metronidazole-resistant lineage of PCR ribotype 010/MLST ST15 isolates that also includes pCD-METRO-containing strains.

CONCLUSIONS:

Our data demonstrate that haem is crucial for medium-dependent metronidazole resistance in C. difficile.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Clostridioides difficile / Infecções por Clostridium Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Clostridioides difficile / Infecções por Clostridium Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda